 | • レポートコード：MRC2012A8132 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ロタウイルスワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ロタウイルスワクチンの種類別市場規模（5価経口、経口）、用途別市場規模（政府機関、民用、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Lanzhou Institution、GSK、Sanofi、 ・地域別グローバル市場分析 2015年-2020年 ・ロタウイルスワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ロタウイルスワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ロタウイルスワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ロタウイルスワクチンの南米市場（ブラジル、アルゼンチン） ・ロタウイルスワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：5価経口、経口 ・用途別分析：政府機関、民用、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rotavirus Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rotavirus Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rotavirus Vaccine market has been segmented into
Pentavalent Oral
Oral
By Application, Rotavirus Vaccine has been segmented into:
Government Institution
Private Sector
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rotavirus Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Rotavirus Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rotavirus Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Rotavirus Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Rotavirus Vaccine Market Share Analysis
Rotavirus Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rotavirus Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rotavirus Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Rotavirus Vaccine are:
Merck
Lanzhou Institution
GSK
Sanofi
Among other players domestic and global, Rotavirus Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rotavirus Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rotavirus Vaccine, with price, sales, revenue and global market share of Rotavirus Vaccine in 2018 and 2019.
Chapter 3, the Rotavirus Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rotavirus Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rotavirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rotavirus Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Rotavirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rotavirus Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pentavalent Oral
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Rotavirus Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Rotavirus Vaccine Market
1.4.1 Global Rotavirus Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lanzhou Institution
2.2.1 Lanzhou Institution Details
2.2.2 Lanzhou Institution Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lanzhou Institution SWOT Analysis
2.2.4 Lanzhou Institution Product and Services
2.2.5 Lanzhou Institution Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rotavirus Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Rotavirus Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rotavirus Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rotavirus Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rotavirus Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.4 France Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rotavirus Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.5 India Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rotavirus Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rotavirus Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rotavirus Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rotavirus Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rotavirus Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rotavirus Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Rotavirus Vaccine Price by Type (2015-2020)
11 Global Rotavirus Vaccine Market Segment by Application
11.1 Global Rotavirus Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Rotavirus Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rotavirus Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Rotavirus Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Rotavirus Vaccine Market Forecast (2021-2025)
12.2.2 Europe Rotavirus Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rotavirus Vaccine Market Forecast (2021-2025)
12.2.4 South America Rotavirus Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rotavirus Vaccine Market Forecast (2021-2025)
12.3 Rotavirus Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Rotavirus Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
12.4 Rotavirus Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Rotavirus Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Rotavirus Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rotavirus Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Rotavirus Vaccine Major Business
Table 9. Merck Rotavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Rotavirus Vaccine Product and Services
Table 12. Merck Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lanzhou Institution Basic Information, Manufacturing Base and Competitors
Table 14. Lanzhou Institution Rotavirus Vaccine Major Business
Table 15. Lanzhou Institution Rotavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Lanzhou Institution SWOT Analysis
Table 17. Lanzhou Institution Rotavirus Vaccine Product and Services
Table 18. Lanzhou Institution Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Rotavirus Vaccine Major Business
Table 21. GSK Rotavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Rotavirus Vaccine Product and Services
Table 24. GSK Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Rotavirus Vaccine Major Business
Table 27. Sanofi Rotavirus Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Rotavirus Vaccine Product and Services
Table 30. Sanofi Rotavirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Rotavirus Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 32. Global Rotavirus Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Rotavirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 34. Global Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 35. Global Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 37. North America Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 38. North America Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 40. Europe Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. Europe Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 42. Europe Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Rotavirus Vaccine Sales by Regions (2015-2020) (K Units)
Table 44. Asia-Pacific Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Rotavirus Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 47. South America Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 48. South America Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Rotavirus Vaccine Sales by Countries (2015-2020) (K Units)
Table 51. Middle East & Africa Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Rotavirus Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Table 54. Global Rotavirus Vaccine Sales by Type (2015-2020) (K Units)
Table 55. Global Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 56. Global Rotavirus Vaccine Revenue by Type (2015-2020) (USD Million)
Table 57. Global Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 58. Global Rotavirus Vaccine Sales by Application (2015-2020) (K Units)
Table 59. Global Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 60. Global Rotavirus Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 61. Global Rotavirus Vaccine Market Share Forecast by Regions (2021-2025)
Table 62. Global Rotavirus Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 63. Global Rotavirus Vaccine Market Share Forecast by Type (2021-2025)
Table 64. Global Rotavirus Vaccine Sales Forecast by Application (2021-2025)
Table 65. Global Rotavirus Vaccine Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Rotavirus Vaccine Picture
Figure 2. Global Sales Market Share of Rotavirus Vaccine by Type in 2019
Figure 3. Pentavalent Oral Picture
Figure 4. Oral Picture
Figure 5. Rotavirus Vaccine Sales Market Share by Application in 2018
Figure 6. Government Institution Picture
Figure 7. Private Sector Picture
Figure 8. Other Picture
Figure 9. Global Rotavirus Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Rotavirus Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Rotavirus Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Rotavirus Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Rotavirus Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Rotavirus Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Rotavirus Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Rotavirus Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Rotavirus Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Rotavirus Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Rotavirus Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Rotavirus Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Rotavirus Vaccine Revenue Market Share by Regions 2019
Figure 62. China Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Rotavirus Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Rotavirus Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Rotavirus Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Rotavirus Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Rotavirus Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Rotavirus Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Rotavirus Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- ロタウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rotavirus Infections Drug Market The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rotavirus Infections Drug Scope and Market Size Rotavirus Infec…
- 経口コレラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cholera Vaccine mar…
- 腸チフスVi多糖ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Typhoid Vi Polysaccharide Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Typhoid Vi …